Drug Shortage Report for PHENOBARBITAL SODIUM INJECTION, USP
Report ID | 168452 |
Drug Identification Number | 02304090 |
Brand name | PHENOBARBITAL SODIUM INJECTION, USP |
Common or Proper name | PHENOBARBITAL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | PHENOBARBITAL SODIUM |
Strength(s) | 120MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 1ML 10LIAM |
ATC code | N03AA |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-09-01 |
Estimated end date | 2022-10-07 |
Actual end date | 2022-10-04 |
Shortage status | Resolved |
Updated date | 2022-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2022-10-05 | English | Compare |
v11 | 2022-10-04 | French | Compare |
v10 | 2022-10-04 | English | Compare |
v9 | 2022-09-27 | French | Compare |
v8 | 2022-09-27 | English | Compare |
v7 | 2022-09-21 | French | Compare |
v6 | 2022-09-21 | English | Compare |
v5 | 2022-09-09 | French | Compare |
v4 | 2022-09-09 | English | Compare |
v3 | 2022-09-02 | English | Compare |
v2 | 2022-09-01 | French | Compare |
v1 | 2022-09-01 | English | Compare |
Showing 1 to 12 of 12